SIGA Technologies, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SIGA research report →
Companywww.siga.com
SIGA Technologies, Inc. , a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus.
- CEO
- Diem Nguyen
- IPO
- 1997
- Employees
- 46
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $322.04M
- P/E
- 15.88
- P/S
- 3.43
- P/B
- 2.12
- EV/EBITDA
- 7.22
- Div Yield
- 13.36%
Profitability
- Gross Margin
- 65.35%
- Op Margin
- 22.00%
- Net Margin
- 21.61%
- ROE
- 10.62%
- ROIC
- 10.03%
Growth & Income
- Revenue
- $94.60M · -31.80%
- Net Income
- $23.30M · -60.65%
- EPS
- $0.33 · -60.24%
- Op Income
- $23.70M
- FCF YoY
- -11.50%
Performance & Tape
- 52W High
- $9.62
- 52W Low
- $4.10
- 50D MA
- $4.78
- 200D MA
- $6.73
- Beta
- 0.85
- Avg Volume
- 674.19K
Get TickerSpark's AI analysis on SIGA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 25, 26 | Miller Larry R. | other | 6,920 |
| Mar 25, 26 | Miller Larry R. | other | 3,526 |
| Mar 25, 26 | Miller Larry R. | other | 6,920 |
| Mar 13, 26 | Luckshire Daniel J | other | 11,503 |
| Mar 13, 26 | Luckshire Daniel J | other | 6,074 |
| Mar 13, 26 | Luckshire Daniel J | other | 55,228 |
| Mar 13, 26 | Luckshire Daniel J | other | 11,503 |
| Mar 13, 26 | Hruby Dennis E | other | 11,445 |
| Mar 13, 26 | Hruby Dennis E | other | 3,955 |
| Mar 13, 26 | Hruby Dennis E | other | 54,942 |
Our SIGA Coverage
We haven't published any research on SIGA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SIGA Report →